SG11201600455XA - Instantly wettable oral film dosage form without surfactant or polyalcohol - Google Patents
Instantly wettable oral film dosage form without surfactant or polyalcoholInfo
- Publication number
- SG11201600455XA SG11201600455XA SG11201600455XA SG11201600455XA SG11201600455XA SG 11201600455X A SG11201600455X A SG 11201600455XA SG 11201600455X A SG11201600455X A SG 11201600455XA SG 11201600455X A SG11201600455X A SG 11201600455XA SG 11201600455X A SG11201600455X A SG 11201600455XA
- Authority
- SG
- Singapore
- Prior art keywords
- polyalcohol
- surfactant
- dosage form
- oral film
- film dosage
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361860345P | 2013-07-31 | 2013-07-31 | |
| PCT/IB2014/002047 WO2015015303A2 (en) | 2013-07-31 | 2014-07-30 | Instantly wettable oral film dosage form without surfactant or polyalcohol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201600455XA true SG11201600455XA (en) | 2016-02-26 |
Family
ID=52428223
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201600455XA SG11201600455XA (en) | 2013-07-31 | 2014-07-30 | Instantly wettable oral film dosage form without surfactant or polyalcohol |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US9301948B2 (en) |
| EP (2) | EP3027179B1 (en) |
| JP (1) | JP6482552B2 (en) |
| KR (1) | KR102272442B1 (en) |
| CN (1) | CN105530921B (en) |
| AU (1) | AU2014298130A1 (en) |
| BR (1) | BR112016002074B1 (en) |
| CA (1) | CA2919442A1 (en) |
| CL (1) | CL2016000160A1 (en) |
| DK (1) | DK3027179T3 (en) |
| ES (1) | ES2706481T3 (en) |
| HK (1) | HK1222796A1 (en) |
| IL (1) | IL243651A0 (en) |
| MX (1) | MX366595B (en) |
| RU (1) | RU2016106907A (en) |
| SG (1) | SG11201600455XA (en) |
| WO (1) | WO2015015303A2 (en) |
| ZA (1) | ZA201600785B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160220480A1 (en) * | 2015-02-03 | 2016-08-04 | Intelgenx Corp. | Oral dosage film exhibiting enhanced mucosal penetration |
| CN105997955B (en) | 2016-06-28 | 2017-09-12 | 力品药业（厦门）有限公司 | A kind of Palonosetron oral cavity membrane and preparation method thereof |
| KR101802183B1 (en) * | 2016-11-16 | 2017-11-28 | 주식회사 유영제약 | Pharmaceutical compositions comprising palonosetron as active ingredient |
| DE102017127452A1 (en) * | 2017-11-21 | 2019-05-23 | Lts Lohmann Therapie-Systeme Ag | Water-soluble polymer adhesive layers |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19646392A1 (en) | 1996-11-11 | 1998-05-14 | Lohmann Therapie Syst Lts | Preparation for use in the oral cavity with a layer containing pressure-sensitive adhesive, pharmaceuticals or cosmetics for dosed delivery |
| JP3460538B2 (en) * | 1997-10-08 | 2003-10-27 | 救急薬品工業株式会社 | Fast dissolving film preparation |
| US7027414B2 (en) * | 2001-08-09 | 2006-04-11 | Hughes Network Systems, Llc | Method, apparatus, and system for identifying and efficiently treating classes of traffic |
| DK1695094T3 (en) | 2003-10-24 | 2013-09-16 | Adhesives Res Inc | Disintegrating films for diagnostic devices |
| AU2005210637B2 (en) * | 2004-01-30 | 2010-09-16 | A.V. Topchiev Institute Of Petrochemical Synthesis | Rapidly dissolving film for delivery of an active agent |
| US20050281757A1 (en) * | 2004-06-17 | 2005-12-22 | Sayed Ibrahim | Oral care film |
| CN101896172A (en) * | 2007-12-11 | 2010-11-24 | 诺瓦提斯公司 | Multi-zone films |
| CA2737307A1 (en) * | 2008-10-14 | 2010-04-22 | Mcneil Ab | Multi portion intra-oral dosage form and use thereof |
| US8715715B2 (en) * | 2008-11-03 | 2014-05-06 | Nal Pharmaceuticals Ltd. | Dosage form for insertion into the mouth |
| US20100285130A1 (en) * | 2009-05-06 | 2010-11-11 | Monosol Rx, Llc | Coating of complexed actives in film formulations |
| CN102665762A (en) * | 2009-11-24 | 2012-09-12 | 巴斯夫欧洲公司 | Film-like pharmaceutical dosage forms |
| US20110136815A1 (en) | 2009-12-08 | 2011-06-09 | Horst Zerbe | Solid oral film dosage forms and methods for making same |
| US20110263606A1 (en) * | 2010-04-26 | 2011-10-27 | Horst Zerbe | Solid oral dosage forms comprising tadalafil |
| JP2012031164A (en) * | 2010-07-06 | 2012-02-16 | Teika Seiyaku Kk | Film-shaped preparation |
| JP5587168B2 (en) * | 2010-12-28 | 2014-09-10 | 花王株式会社 | Cleaning composition for medical equipment |
| US20120282191A1 (en) * | 2011-01-17 | 2012-11-08 | Takeda Pharmaceutical Company Limited | Orally dispersible tablet |
| KR101303479B1 (en) * | 2011-07-28 | 2013-09-06 | (주)씨엘팜 | Composition for edible film and pharmaceutical preparation for edible film containing drugs |
| MX370064B (en) * | 2013-05-10 | 2019-11-29 | Ctc Bio Inc | Film preparation containing donepezil-free base and method for producing same. |
-
2014
- 2014-07-30 ES ES14832172T patent/ES2706481T3/en active Active
- 2014-07-30 SG SG11201600455XA patent/SG11201600455XA/en unknown
- 2014-07-30 EP EP14832172.2A patent/EP3027179B1/en active Active
- 2014-07-30 KR KR1020167005581A patent/KR102272442B1/en active IP Right Grant
- 2014-07-30 EP EP18192084.4A patent/EP3427732A1/en not_active Withdrawn
- 2014-07-30 JP JP2016530631A patent/JP6482552B2/en active Active
- 2014-07-30 DK DK14832172.2T patent/DK3027179T3/en active
- 2014-07-30 RU RU2016106907A patent/RU2016106907A/en not_active Application Discontinuation
- 2014-07-30 US US14/447,071 patent/US9301948B2/en active Active
- 2014-07-30 CN CN201480043392.8A patent/CN105530921B/en active Active
- 2014-07-30 AU AU2014298130A patent/AU2014298130A1/en not_active Abandoned
- 2014-07-30 BR BR112016002074-0A patent/BR112016002074B1/en active IP Right Grant
- 2014-07-30 MX MX2016001399A patent/MX366595B/en active IP Right Grant
- 2014-07-30 WO PCT/IB2014/002047 patent/WO2015015303A2/en active Application Filing
- 2014-07-30 CA CA2919442A patent/CA2919442A1/en not_active Abandoned
-
2016
- 2016-01-18 IL IL243651A patent/IL243651A0/en unknown
- 2016-01-21 CL CL2016000160A patent/CL2016000160A1/en unknown
- 2016-02-04 ZA ZA2016/00785A patent/ZA201600785B/en unknown
- 2016-09-20 HK HK16111016.9A patent/HK1222796A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2016527262A (en) | 2016-09-08 |
| CA2919442A1 (en) | 2015-02-05 |
| WO2015015303A2 (en) | 2015-02-05 |
| CN105530921A (en) | 2016-04-27 |
| ZA201600785B (en) | 2017-04-26 |
| CL2016000160A1 (en) | 2016-11-18 |
| DK3027179T3 (en) | 2019-02-11 |
| AU2014298130A1 (en) | 2016-02-11 |
| MX366595B (en) | 2019-07-15 |
| EP3027179A2 (en) | 2016-06-08 |
| IL243651A0 (en) | 2016-02-29 |
| RU2016106907A (en) | 2017-09-01 |
| EP3027179B1 (en) | 2018-10-17 |
| BR112016002074B1 (en) | 2023-01-24 |
| MX2016001399A (en) | 2016-10-28 |
| US20150038540A1 (en) | 2015-02-05 |
| ES2706481T3 (en) | 2019-03-29 |
| WO2015015303A3 (en) | 2015-05-21 |
| BR112016002074A2 (en) | 2017-08-01 |
| KR102272442B1 (en) | 2021-07-02 |
| HK1222796A1 (en) | 2017-07-14 |
| EP3027179A4 (en) | 2017-02-22 |
| JP6482552B2 (en) | 2019-03-13 |
| CN105530921B (en) | 2021-02-26 |
| US9301948B2 (en) | 2016-04-05 |
| KR20160089335A (en) | 2016-07-27 |
| EP3427732A1 (en) | 2019-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1225624A1 (en) | Oral dispersible films | |
| IL274024A (en) | Oral compositions | |
| IL246377A0 (en) | Oral pharmaceutical composition | |
| EP3065716C0 (en) | Formulations | |
| GB201302672D0 (en) | Image velocimetry | |
| HK1219061A1 (en) | Emulsion formulations | |
| SG11201509319VA (en) | Film | |
| EP2955024A4 (en) | Release film | |
| HK1215678A1 (en) | Oral composition | |
| EP2985324A4 (en) | Film comprising copolymer or composition | |
| EP2982505A4 (en) | Functional film | |
| IL246301B (en) | Film compositions for oral use | |
| GB201319792D0 (en) | Formulations | |
| HK1225306A1 (en) | Dental composition | |
| HK1214951A1 (en) | Ophthalimic formulations | |
| EP2982509A4 (en) | Applied film | |
| HK1222796A1 (en) | Instantly wettable oral film dosage form without surfactant or polyalcohol | |
| EP2980141A4 (en) | Film | |
| IL244601B (en) | Camera | |
| EP2950120A4 (en) | Camera | |
| GB201305103D0 (en) | An oral dosage form | |
| GB201308933D0 (en) | Paediatric composition | |
| GB2520315B (en) | Oral Syringes | |
| GB201302388D0 (en) | Enhanced instant camera | |
| UA28970S (en) | PACKAGING FOR CRACKERS "CREAMY" |